Wegovy®

(Semaglutide)

Medi-Weightloss offers FDA-approved injectable and oral weight loss medications, including Wegovy® pill.

Wegovy® (semaglutide) pen

FDA-approved, injectable weight loss medication

Wegovy is specifically indicated for chronic weight management in adults with obesity or overweight conditions and works by activating the GLP-1 receptors to help reduce appetite and increase feelings of fullness — ultimately contributing to weight loss.

As with any medication, it’s important to use Wegovy under the supervision and guidance of a healthcare professional.

Wegovy
Wegovy® (semaglutide) pill

Is Wegovy® available as a pill?

Yes, Wegovy® (semaglutide) is available as a once-daily prescription pill. This oral GLP-1 medication is FDA-approved for long-term weight management in adults with obesity or overweight who have at least one weight-related medical condition. When combined with a reduced-calorie diet and increased physical activity, Wegovy® can help eligible adults lose weight and maintain their weight loss.

Wegovy® Prescription Options

Wegovy® pill vs. injection: What’s the difference?

Both the Wegovy® pill and injection contain the same active ingredient, semaglutide, but differ in how they are administered. The Wegovy® pill is taken once daily in the morning on an empty stomach with no more than 4 ounces of plain water. The tablet should be swallowed whole, and patients must wait at least 30 minutes before eating, drinking, or taking other oral medications to support proper medication absorption. The Wegovy® injection is administered once weekly.

Not sure which option is best for you? At Medi-Weightloss®, we review your health history, current medications, and weight loss goals to help you understand your treatment options. If medication is appropriate, your personalized plan may include nutrition guidance, medical supervision, and ongoing support. Ask the experts at your local Medi-Weightloss® clinic whether Wegovy® is right for you.

139 Locations—and Growing

Find a Medi-Weightloss near you

You have access to a proven, scientifically-based weight loss clinic right in your neighborhood.

Medi-Weightloss Program

The Medi-Weightloss Program is a physician-supervised and clinically proven approach to medical weight loss that helps our patients achieve and maintain a healthy weight.

Wegovy frequently asked questions

Wegovy (semaglutide) is a weekly injection approved by the U.S. Food and Drug Administration (FDA) in 2021 for long-term weight management.
We are an established network of weight loss providers with a track record of nearly 20 years. Each patient receives individualized care and education through our medically-supervised and clinically-proven program.
Wegovy mimicks a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food consumption. Your body’s natural GLP-1 hormones and Wegovy work to control insulin, lower blood sugar and slow down stomach emptying. This can help you feel fuller faster, leading to reduced appetite, improved portion control and fewer cravings.

Patients taking Wegovy lost an average of 35 lbs compared to 6 lbs in the placebo group. Overall, after 68 weeks, 83% of adults taking Wegovy lost 5% or more of their weight compared to 31% of adults taking a placebo.

Source: FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014. US Food and Drug Administration. Accessed Jan. 4, 2024, at https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014

Wegovy is administered once a week as an injection. The dose is increased gradually over 16-20 weeks to monitor and reduce potential side effects.
The cost of your medication will vary. We will assist you in obtaining coverage and will work with you and your budget to select an affordable weight loss medication that’s right for you. At weekly visits, your provider may change prescriptions or dosages based on your progress.
Insurance coverage varies by location and by plan. Contact us to find out what your plan covers.

Wegovy® (semaglutide) is an FDA-approved, once-weekly injection for chronic weight management in adults with obesity or overweight conditions. It mimics the natural hormone GLP-1 to control insulin, lower blood sugar, and slow stomach emptying — helping you feel fuller faster, reduce cravings, and lose weight. In clinical trials, Wegovy patients lost an average of 35 lbs vs. 6 lbs on placebo, and 83% lost at least 5% of body weight at 68 weeks. We prescribe Wegovy as part of your supervised Medi-Weightloss plan.

We accept insurance

Find out if we are contracted with your insurance carrier.